alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
I 

118TH CONGRESS 

2D SESSION H. R. 7789 

To prohibit the Department of Defense from offering services through, or 

maintaining a business relationship with, Tutor.com. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 21, 2024 

Ms. STEFANIK introduced the following bill; which was referred to the 

Committee on Armed Services 

A BILL 

To prohibit the Department of Defense from offering services 

through, or maintaining a business relationship with, 

Tutor.com. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Ban Chinese Com5 munist Party Access to U.S. Military Students Act of 

6 2024’’. 

7 SEC. 2. PROHIBITION OF DEPARTMENT OF DEFENSE 

8 USAGE OF TUTOR.COM. 

9 (a) FINDINGS.—Congress makes the following find10 ings: 


ssavage on LAPJG3WLY3PROD with BILLS
2 

•HR 7789 IH

1 (1) The website Tutor.com is a long-standing 

2 provider of tutoring services to members of the 

3 United States Armed Forces and their families. 

4 (2) In January 2022, Primavera Capital Group, 

5 a Chinese-owned corporation associated with 

6 TikTok’s parent company, ByteDance, acquired 

7 Tutor.com and The Princeton Review (TPR Edu8 cation LLC) from ST Unitas. 

9 (3) While providing educational services, 

10 Tutor.com collects personal data on users, such as 

11 location, internet protocol addresses, and contents of 

12 the tutoring sessions. 

13 (4) As the national security laws of the People’s 

14 Republic of China require companies to release con15 fidential business and customer data to the Govern16 ment of the People’s Republic of China, the United 

17 States is paying to expose the private information of 

18 members of the United States Armed Forces and 

19 their children to the Chinese Communist Party. 

20 (b) PROHIBITION.— 

21 (1) IN GENERAL.—The Department of Defense 

22 shall— 

23 (A) cease offering services through 

24 Tutor.com not later than 30 days after the date 

25 of the enactment of this Act; and 


ssavage on LAPJG3WLY3PROD with BILLS
3 

•HR 7789 IH

1 (B) terminate any business relationships 

2 with Tutor.com as soon as legally possible. 

3 (2) FUTURE RELATIONSHIPS.—The Depart4 ment shall not enter into any other relationship with 

5 Tutor.com as long as Tutor.com is owned by 

6 Primavera Capital Group or any other entity owned 

7 or controlled by nationals of the People’s Republic of 

8 China. 

Æ 


ssavage on LAPJG3WLY3PROD with BILLS
Editorial Note on Part 874
Editorial Note: Nomenclature changes to part 874 appear at 73 FR 35341, June 23, 2008.

§ 874.4450 Powered insertion system for a cochlear implant electrode array. ( a ) *Identification.* A powered insertion system for a cochlear implant electrode array is a prescription device used to assist in placing an electrode array into the cochlea.
( b ) *Classification.* Class II (special controls). The special controls for this device are: ( 1 ) Clinical performance testing must demonstrate that the device performs as intended under anticipated conditions of use, including evaluation of all adverse events.
( 2 ) Non-clinical performance testing must demonstrate that the device performs as intended under anticipated conditions of use. Testing must include: ( i ) Verification of cochlear implant attachment force, release force, and insertion speed;
( ii ) Testing to demonstrate the device does not damage or degrade the cochlear implant (including the lead and array portions of the cochlear implant); and
( iii ) Comparison testing with manual insertion to evaluate: ( A ) Differences in cochlear implant array insertion force associated with use of the device; and
( B ) Intracochlear placement of the cochlear implant array (intended scala placement and array insertion depth, together with minimal array tip foldover and cochlear scala translocation).
( 3 ) Usability testing in a simulated hospital environment with an anatomically relevant model (*e.g.,* cadaver testing) that evaluates the following: ( i ) Successful use to aid in placement of the electrode array into the cochlea; and
( ii ) Harms caused by use errors observed.
( 4 ) Changes in cochlear implant compatibility are determined to significantly affect the safety or effectiveness of the device and must be validated through performance testing or a rationale for omission of any testing.
( 5 ) The patient-contacting components of the device must be demonstrated to be biocompatible.
( 6 ) Performance testing must demonstrate the electromagnetic compatibility, electrical safety, and thermal safety of the device.
( 7 ) The patient-contacting components of the device must be demonstrated to be sterile and non-pyrogenic.
( 8 ) Performance testing must support the shelf life of device components provided sterile by demonstrating continued sterility, package integrity, and device functionality over the labeled shelf life.
( 9 ) Software verification, validation, and hazard analysis must be performed for any software components of the device.
( 10 ) Labeling must include: ( i ) The recommended training for the safe use of the device;
( ii ) Summary of the relevant clinical and non-clinical testing pertinent to use of the device with compatible electrode arrays; and
( iii ) A shelf life.
[88 FR 979, Jan. 6, 2023]
[Federal Register Volume 75, Number 45 (Tuesday, March 9, 2010)]
[Notices]
[Page 10808]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-4753]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Nursing Research; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Nursing Research, 
Special Emphasis Panel, NINR Loan Repayment Program Review (L30/
L40).
    Date: March 29, 2010.
    Time: 9 a.m. to 12 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, One Democracy Plaza, 6701 
Democracy Boulevard, Ste. 710, Bethesda, MD 20892. (Telephone 
Conference Call)
    Contact Person: Mario Rinaudo, MD, Scientific Review 
Administrator, Office of Review, National Institute of Nursing 
Research, National Institutes of Health, 6701 Democracy Blvd (DEM 
1), Suite 710, Bethesda, MD 20892, 301-594-5973, 
<a href="/cdn-cgi/l/email-protection#aec3dcc7c0cfdbcac1eec3cfc7c280c0c7c680c9c1d8"><span class="__cf_email__" data-cfemail="5e332c37303f2b3a311e333f37327030373670393128">[email protected]</span></a>.
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.

(Catalogue of Federal Domestic Assistance Program Nos. 93.361, 
Nursing Research, National Institutes of Health, HHS)

    Dated: March 1, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-4753 Filed 3-8-10; 8:45 am]
BILLING CODE 4140-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Editorial Note on Part 868
Editorial Note: Nomenclature changes to part 868 appear at 73 FR 35341, June 23, 2008.

§ 868.1640 Helium gas analyzer. ( a ) *Identification.* A helium gas analyzer is a device intended to measure the concentration of helium in a gas mixture during pulmonary function testing. The device may use techniques such as thermal conductivity, gas chromatography, or mass spectrometry.
( b ) *Classification.* Class II (performance standards).
EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(Chief Financial Officer)

In connection with the Quarterly Report of CEC Entertainment, Inc. (the Company) on Form
10-Q for the quarter ended March 30, 2008 as filed with the Securities and Exchange Commission on the date hereof (the Report), the undersigned certifies that:



| | (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ---------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------



|            |  |                          
|----------- |  | -------------------------
|May 8, 2008 |  | /s/ Christopher D. Morris
|            |  | Christopher D. Morris    
|            |  | Chief Financial Officer
| (1)   | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|-----------------|-----------------------------------------------------------------------------------------------------------------------|

| (2)   | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|-----------------|------------------------------------------------------------------------------------------------------------------------------------------------------|

|          | CEC Entertainment, Inc. |                                  |
|---------------|-------------------------|---------------------------------------|
|          |                    |                                  |   |
| July 30, 2009 | By:                     | /s/ Michael H. Magusiak          |   |
|          |                    | Michael H. Magusiak                   |   |
|          |                    | President and Chief Executive Officer |   |
|          |                    |                                  |   |
EXHIBIT 11 - CALCULATION OF NET INCOME (LOSS) PER COMMON SHARE


                                  MICROAGE, INC
                 NET INCOME (LOSS) PER COMMON SHARE CALCULATION
                                 (in thousands)


                                                          Quarter ended
                                                     ---------------------------
                                                     February 1,     February 2,
                                                        1998            1997
                                                     -----------     -----------
BASIC
  Weighted average common shares                       19,456           16,242
                                                     --------          -------

DILUTED
  Weighted average shares from
   primary calculation                                 19,456           16,242

  Dilutive effect of stock options
   and warrants                                            --              985
                                                     --------          -------
    Weighted average common and common
     equivalent shares outstanding - diluted           19,456           17,227
                                                     --------          -------

NET INCOME  (LOSS)                                   $ (6,116)         $ 5,070

Net income (loss) per common and common
 equivalent share:
  Basic                                              $  (0.31)         $  0.31
                                                     ========          =======
  Diluted                                            $  (0.31)         $  0.29
                                                     ========          =======
**Exhibit 32.1**

SECTION 1350CERTIFICATION 

        Inconnection with the accompanying Quarterly Report on Form 10-Q of Penn TreatyAmerican Corporation (the “Company”) for the period ended September 30, 2005 asfiled with the Securities and Exchange Commission, I, William W. Hunt, President and ChiefExecutive Officer of the Company, certify pursuant to 18 U.S.C. Section §1350,as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002 that to the best of myknowledge:
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE FORM
10-QSB FOR THE QUARTER ENDED JUNE 30, 1999 AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FORM 10-QSB.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               JUN-30-1999
<CASH>                                         933,537
<SECURITIES>                                   179,165
<RECEIVABLES>                                1,311,993
<ALLOWANCES>                                         0
<INVENTORY>                                    836,000
<CURRENT-ASSETS>                             3,459,080
<PP&E>                                       6,035,998
<DEPRECIATION>                               1,861,964
<TOTAL-ASSETS>                               7,640,614
<CURRENT-LIABILITIES>                          898,929
<BONDS>                                      1,277,354
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                     1,601,916
<OTHER-SE>                                   3,690,455
<TOTAL-LIABILITY-AND-EQUITY>                 7,640,614
<SALES>                                      3,893,188
<TOTAL-REVENUES>                             3,909,962
<CGS>                                        1,903,009
<TOTAL-COSTS>                                1,176,991
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              47,163
<INCOME-PRETAX>                                782,799
<INCOME-TAX>                                   303,197
<INCOME-CONTINUING>                            479,602
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   479,602
<EPS-BASIC>                                        .13
<EPS-DILUTED>                                      .13


</TABLE>
SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

   Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934

Date of Report (Date of earliest event reported)                 June 17, 2003
                                                                 ---------------

                               WEGENER CORPORATION
--------------------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)

          Delaware                       0-11003                  81-0371341
--------------------------------------------------------------------------------
(State or other jurisdiction     (Commission File Number)       (IRS Employer
     of incorporation)                                       Identification No.)

11350 Technology Circle, Duluth, Georgia                           30097
--------------------------------------------------------------------------------
(Address of principal executive offices)                         (Zip Code)

Registrant's telephone number, including area code                (770) 623-0096
                                                                  --------------

                                       N/A
--------------------------------------------------------------------------------
          (Former name or former address, if changed since last report)


<PAGE>


Item 7. Financial Statements and Exhibits

      The press release issued by Wegener Corporation on June 17, 2003
announcing its results for its third fiscal quarter of 2003 is filed herewith as
Exhibit 99.1.


Item 9. Regulation FD Disclosure and Item 12. Disclosure of Results of
Operations and Financial Condition

      On June 17, 2003, Wegener Corporation issued a press release announcing
its results for its third fiscal quarter of 2003. A copy of the press release is
furnished as part of this report and incorporated by reference in response to
Items 9 and 12 of this Form 8-K.


<PAGE>

                                    SIGNATURE

      Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                       WEGENER CORPORATION

Date: June 17, 2003                    By: /s/ Robert A. Placek
                                           -------------------------------------
                                           Robert A. Placek
                                           President and Chief Executive Officer
[Federal Register Volume 75, Number 40 (Tuesday, March 2, 2010)]
[Notices]
[Page 9414]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-4225]


=======================================================================
-----------------------------------------------------------------------

FEDERAL RESERVE SYSTEM


Change in Bank Control Notices; Acquisition of Shares of Bank or 
Bank Holding Companies

    The notificants listed below have applied under the Change in Bank 
Control Act (12 U.S.C. 1817(j)) and Sec. [thinsp]225.41 of the Board's 
Regulation Y (12 CFR 225.41) to acquire a bank or bank holding company. 
The factors that are considered in acting on the notices are set forth 
in paragraph 7 of the Act (12 U.S.C. 1817(j)(7)).
    The notices are available for immediate inspection at the Federal 
Reserve Bank indicated. The notices also will be available for 
inspection at the office of the Board of Governors. Interested persons 
may express their views in writing to the Reserve Bank indicated for 
that notice or to the offices of the Board of Governors. Comments must 
be received not later than March 17, 2010.
    A. Federal Reserve Bank of Atlanta (Steve Foley, Vice President) 
1000 Peachtree Street, N.E., Atlanta, Georgia 30309:
    1. Anthony Jennings Roy, III, Marksville, Louisiana; to retain 
voting shares of Mansura Bancshares, Inc., Mansura, Louisiana, and 
thereby indirectly retain voting shares of The Cottonport Bank, 
Cottonport, Louisiana.

    Board of Governors of the Federal Reserve System, February 25, 
2010.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. 2010-4225 Filed 3-1-10; 8:45 am]
BILLING CODE 6210-01-S
Editorial Note on Part 872
Editorial Note: Nomenclature changes to part 872 appear at 73 FR 35341, June 23, 2008.

§ 872.5525 Preformed tooth positioner. ( a ) *Identification.* A preformed tooth positioner is a plastic device that is an impression of a perfected bite intended to prevent a patient's teeth from shifting position or to move teeth to a final position after orthodontic appliances (braces) have been removed. The patient bites down on the device for several hours a day to force the teeth into a final position or to maintain the teeth in their corrected position.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 872.9.
[52 FR 30097, Aug. 12, 1987, as amended at 59 FR 63009, Dec. 7, 1994; 66 FR 38799, July 25, 2001]
# C_2014194EN.01003805.xml

| 24.6.2014 | EN | Official Journal of the European Union | C 194/38 |
| --- | --- | --- | --- |

24.6.2014

EN

Official Journal of the European Union

C 194/38

---

Order of the General Court of 5 May 2014 — Volkswagen v OHIM (StartUp)

(Case T-156/14) (1)

1

2014/C 194/55

Language of the case: German

The President of the Eighth Chamber has ordered that the case be removed from the register.

---

(1)  OJ C 135, 5.5.2014.

1

---
Editorial Note on Part 868
Editorial Note: Nomenclature changes to part 868 appear at 73 FR 35341, June 23, 2008.

§ 868.1575 Gas collection vessel. ( a ) *Identification.* A gas collection vessel is a container-like device intended to collect a patient's exhaled gases for subsequent analysis. It does not include a sampling pump.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 868.9.
[47 FR 31142, July 16, 1982, as amended at 61 FR 1119, Jan. 16, 1996; 66 FR 38793, July 25, 2001]
# C_2016232EN.01001301.xml

| 27.6.2016 | EN | Official Journal of the European Union | C 232/13 |
| --- | --- | --- | --- |

27.6.2016

EN

Official Journal of the European Union

C 232/13

---

Judgment of the General Court of 12 May 2016 — Hamr — Sport v Commission

(Case T-693/14) (1)

1

((State aid - Sports facilities provided by non-profit organisations - Operating or investment subsidies seeking to enable the construction, operation, maintenance, reconstruction or development of sports facilities which are non-profit - Decision declaring the aid to be compatible with the internal market - Article 107(3)(c) TFEU - Action for annulment - Individual concern - Notion of interested party - Admissibility - No effect on the trading conditions to an extent contrary to the common interest - No doubts which justify initiating the formal investigation procedure))

(2016/C 232/16)

Language of the case: Czech

Parties

Parties

Applicant: Hamr — Sport a.s. (Prague, Czech Republic) (represented by: T. Capoušek, lawyer)

Applicant:

Defendant: European Commission (represented by: T. Maxian Rusche and P. Němečková, acting as Agents)

Defendant:

Intervener in support of the defendant: Czech Republic (represented by: M. Smolek, J. Vláčil and T. Müller, acting as Agents)

Intervener in support of the defendant:

Re:

Re:

Application based on Article 263 TFEU and seeking the annulment of Commission Decision C (2014) 3602 final of 11 June 2014 relating to State aid SA.33575 (2013/NN) — Czech Republic in favour of non-profit sports facilities granted by central public institutions.

Operative part of the judgment

Operative part of the judgment

The Court:

| 1. | Dismisses the action; |
| --- | --- |

1.

Dismisses the action;

| 2. | Orders Hamr — Sport a.s. to pay the costs, except those incurred by the Czech Republic. |
| --- | --- |

2.

Orders Hamr — Sport a.s. to pay the costs, except those incurred by the Czech Republic.

| 3. | The Czech Republic must be ordered to bear its own costs. |
| --- | --- |

3.

The Czech Republic must be ordered to bear its own costs.

---

(1)  OJ C 7, 12.1.2015.

1

---